查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715611

心臟安全服务市场按服务类型、类型、应用和最终用户划分－2025-2030 年全球预测

Cardiac Safety Services Market by Service Type, Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 2023 年心臟安全服务市场价值将达到 12.2 亿美元，2024 年将成长至 13.3 亿美元，到 2030 年将达到 23.4 亿美元，复合年增长率为 9.71%。

主要市场统计数据
基准年2023年 12.2亿美元
预计2024年 13.3亿美元
预测年份 2030 23.4亿美元
复合年增长率（%） 9.71%

心臟安全服务在确保新的医疗创新以不折不扣的安全性推向市场方面发挥着至关重要的作用。在当今快速发展的医疗保健环境中，这些服务在改善患者治疗效果的同时，也保持了监管的完整性。透过严格的测试方法、尖端的诊断技术以及全面的心血管评估方法，该行业成功地弥合了临床研究与患者照护之间的差距。

该报告对心臟安全服务领域进行了深入研究，检验了当前趋势、变革驱动因素、细分见解、区域和公司特定动态。其目标不仅是提供市场发展的概述，而且还要为相关人员提供资源，以便他们在日益激烈的竞争环境中做出明智的决策并抓住新的机会。

随着先进技术和数据分析的普及，从初步筛检到最终的法规遵循，心臟安全工作流程的每个步骤都得到了显着增强。随着该领域的不断成熟，创新解决方案的持续整合将开启临床安全评估的新篇章，有望提高准确性、缩短时间并改善患者的治疗效果。

一场变革将重新定义心臟安全服务的范式

近年来，随着技术进步的加快和监管要求的不断变化，心臟安全服务领域发生了变革性的变化。从远端监控系统到人工智慧增强诊断演算法的数位健康工具的快速整合正在重塑传统方法并加速我们评估心血管安全的方式。

这种转型转变正在推动整个产业的变革，其中数据主导的洞察力补充了传统的临床评估。相关人员越来越多地掌握准确、即时的信息，这不仅可以改善潜在治疗方法的早期影响评估，而且还为法规遵从性提供了可靠的纵向数据。云端运算、高效能分析和下一代成像技术的融合为更灵活、更具适应性的安全评估铺平了道路。

此外，从製药巨头到创新新兴企业的多个领域的合作正在加强生态系统并为跨行业协同效应创造机会。这种专业知识的整合正在提高流程效率、缩短临床试验週期并确保安全始终处于治疗开发创新的前沿。最终，这些变化代表着模式转移，其中品质、精确度和速度至关重要，开创了心血管安全保障的新时代。

跨服务类型、应用程式和最终用户的关键细分洞察

心臟安全服务市场的細項分析揭示了一个多维框架，突显了该行业的多样性和复杂性。在根据服务类型分析市场时，该研究区分了血压测量服务、心血管影像服务、心电图或动态心电图测量服务以及全面的 QT 测试。每个类别都反映了患者和治疗评估的细微方面，并有助于更广泛地了解心血管风险管理和临床安全。

关于服务模型，我们区分整合服务和独立服务。这种二分法不仅阐明了营运动态，而且揭示了服务交付的不同整体性水平，突显了频谱解决方案相对于分隔的、特定任务的方法的优势。当根据应用来审视市场时，细分变得更加细化，药物和设备开发与监管合规要求之间存在明显的分歧。该部门帮助相关人员了解现代临床试验所需的双重关注，即在技术创新和严格的监督框架之间取得平衡。

此外，按最终用户细分可提供包括委外研发机构、製药和生物製药公司以及研究机构在内的观点。这种多层次的使用者类型分类凸显了不同的相关人员有自己的优先事项和营运挑战，从而需要製定量身定制的策略。整合这些不同的细分因素可以提供对市场的整体情况，使决策者能够策略性地提供满足各个细分市场复杂需求的产品。

透过将这些方面纳入分析框架，报告明确指出，一刀切的做法不再可行。相反，针对服务类型、交付方式、应用重点和最终用户要求等具体情况的客製化策略对于在当今快速发展的心臟安全服务市场中取得成功至关重要。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球心臟相关疾病发生率不断上升，新药开发需求不断增长
      • 製药公司越来越多地使用CRO外包服务
    • 限制因素
      • 对心臟安全技术与现有医疗IT基础设施整合的担忧
    • 机会
      • 持续整合人工智慧和机器学习，提高心臟监测准确性
      • 增加公共和私人对新临床研究的投资
    • 任务
      • 与心臟安全服务相关的监管合规性和奖励
  • 市场区隔分析
    • 服务类型：对 Holter 监测服务的需求不断增长，用于监测药物对心率的影响
    • 类型：利用具有灵活性和精确心臟参数定位的独立服务
    • 应用：药物和医疗设备开发的重点增强了对心臟副作用的检测
    • 最终使用者：心臟安全的创新和临床试验中合约研究组织不断演变的角色
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 心臟安全服务市场（依服务类型）

  • 血压测量服务
  • 心血管影像服务
  • ECG 或 Holter 监测服务
  • 彻底的QT研究

7. 心臟安全服务市场（按类型）

  • 整合服务
  • 独立服务

8. 心臟安全服务市场（按应用）

  • 药品和医疗设备开发
  • 监理合规要求

9. 心臟安全服务市场（依最终用户）

  • 合约研究组织
  • 製药和生物製药
  • 研究组织

10.美洲心臟安全服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

11.亚太心臟安全服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12.欧洲、中东和非洲心臟安全服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023年市场占有率分析
  • 2023年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • ACM Global Laboratories
  • Advarra, Inc.
  • Banook Group
  • Biotrial
  • Celerion
  • Certara, Inc.
  • Charles River Laboratories International, Inc.
  • Circle Cardiovascular Imaging Inc.
  • Clario
  • Clyde Biosciences Limited
  • Eurofins Scientific SE
  • GE HealthCare Technologies Inc.
  • ICON PLC
  • IQVIA Holdings Inc.
  • Koninklijke Philips NV
  • Laboratory Corporation of America Holdings
  • Medpace, Inc.
  • MERIT CRO, Inc.
  • Metrion Biosciences Limited
  • Ncardia Services BV
  • NEXEL Co., Ltd.
  • Octagos Health, Inc.
  • Parexel International Corporation
  • PhysioStim SAS
  • PPD, Inc. by Thermo Fisher Scientific Inc.
  • Richmond Pharmacology Limited
  • Shanghai Medicilon Inc.
  • Worldwide Clinical Trials
Product Code: MRR-034230D3E2D5

The Cardiac Safety Services Market was valued at USD 1.22 billion in 2023 and is projected to grow to USD 1.33 billion in 2024, with a CAGR of 9.71%, reaching USD 2.34 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 1.22 billion
Estimated Year [2024] USD 1.33 billion
Forecast Year [2030] USD 2.34 billion
CAGR (%) 9.71%

Cardiac safety services play a pivotal role in ensuring that new medical innovations reach the market with an uncompromised safety profile. In today's fast-evolving healthcare environment, these services sustain regulatory integrity while enhancing patient outcomes. Through rigorous testing methodologies, cutting-edge diagnostic techniques, and a comprehensive approach to cardiovascular evaluations, the industry has successfully bridged the gap between clinical research and patient care.

This report provides an in-depth exploration of the cardiac safety services sector, examining current trends, transformation drivers, segmentation insights, and regional and company-specific dynamics. The objective is not only to outline the evolution of the market but also to serve as a resource that empowers stakeholders to make informed decisions and seize emerging opportunities in an increasingly competitive landscape.

With the proliferation of advanced technologies and data analytics, every step in the cardiac safety workflow-from preliminary screening to final regulatory compliance-has witnessed significant enhancements. As the sector continues to mature, ongoing integration of innovative solutions begins a new chapter in clinical safety evaluation, promising enhanced accuracy, reduced timelines, and improved patient outcomes.

Transformative Shifts Redefining the Cardiac Safety Services Paradigm

Recent years have witnessed transformative shifts in the cardiac safety services domain, driven by the accelerated pace of technological advancements and evolving regulatory demands. The rapid integration of digital health tools, from remote monitoring systems to AI-enhanced diagnostic algorithms, is reshaping traditional methodologies and accelerating the way cardiovascular safety is assessed.

These transformative shifts are catalyzing an industry-wide evolution where data-driven insights now complement traditional clinical evaluations. Stakeholders are increasingly equipped with precise, real-time information that not only improves the initial impact assessment of therapeutic candidates but also provides robust longitudinal data for regulatory compliance. The convergence of cloud computing, high-performance analytics, and next-generation imaging techniques has paved the way for more agile and adaptive safety assessments.

Moreover, collaborations across multiple sectors-ranging from pharmaceutical giants to innovative startups-are enhancing the ecosystem, creating opportunities for cross-industry synergy. This melding of expertise is driving improvements in process efficiencies, reducing the cycle time for clinical trials, and ensuring that safety remains at the forefront of innovation in therapeutic development. Ultimately, these changes signify a paradigm shift where quality, precision, and speed are paramount, precipitating a new era of cardiovascular safety assurance.

Key Segmentation Insights Across Service Types, Applications, and End Users

The segmentation analysis of the cardiac safety services market reveals a multidimensional framework that underscores the diversity and complexity of the industry. When analyzing the market based on service type, the study differentiates among blood pressure measurement services, cardiovascular imaging services, ECG or holter measurement services, and thorough QT studies. Each of these categories reflects a nuanced aspect of patient assessment and therapeutic evaluation, contributing to a broader understanding of cardiovascular risk management and clinical safety.

In terms of service models, the analysis distinguishes between integrated services and standalone services. This dichotomy not only provides clarity on operational dynamics but also illuminates the varying levels of comprehensiveness in service delivery, highlighting the benefits of full-spectrum solutions versus compartmentalized, task-specific approaches. Further granularity in the segmentation is observed when the market is examined based on applications, where there is a clear bifurcation between drug and device development and regulatory compliance requirements. This delineation helps stakeholders appreciate the dual focus required in modern clinical trials, balancing innovation with stringent oversight frameworks.

Additionally, the segmentation by end-user presents a perspective that includes contract research organizations, pharmaceutical and biopharma entities, and research institutes. This layered categorization of user types accentuates the tailored strategies employed by different stakeholders, each of whom carries unique priorities and operational challenges. The integration of these various segmentation factors provides a holistic view of the market, allowing decision-makers to strategically align their offerings with the intricacies of demand across different segments.

By embedding these dimensions into the analytical framework, the report clearly illustrates that a one-size-fits-all approach is no longer viable. Instead, a customized strategy that caters to the specifics of service type, delivery method, application focus, and end-user requirements is essential for success in today's rapidly evolving cardiac safety services market.

Based on Service Type, market is studied across Blood Pressure Measurement Services, Cardiovascular Imaging Services, ECG or Holter Measurement Services, and Thorough QT Studies.

Based on Type, market is studied across Integrated Services and Standalone Services.

Based on Application, market is studied across Drug & Device Development and Regulatory Compliance Requirements.

Based on End User, market is studied across Contract Research Organizations, Pharmaceutical & Biopharma, and Research Institutes.

Regional Insights Highlighting Evolving Market Dynamics

When evaluating the geographical dynamics of the cardiac safety services market, it is imperative to consider the distinct characteristics of three major regions: the Americas; Europe, Middle East & Africa; and Asia-Pacific. Each region exhibits unique trends and opportunities that drive their specific market behaviors.

In the Americas, a combination of well-established healthcare infrastructures and dynamic biopharma sectors has fostered an environment conducive to rapid technological adoption and innovation. Regulatory bodies in the region continue to emphasize the integration of advanced monitoring systems and stringent safety protocols. Meanwhile, Europe, Middle East & Africa present a mosaic of markets where consolidated healthcare systems and progressive regulatory frameworks promote cross-border collaborations and research initiatives. This region is characterized by both mature markets with robust safety standards and emerging markets that are adopting cutting-edge cardiac evaluation practices.

Asia-Pacific has emerged as a frontier for growth and innovation, buoyed by a rapidly expanding patient base and significant investments in healthcare technology. The region is becoming increasingly important for clinical trials, owing to a combination of cost-effectiveness and access to diverse patient populations. This geographic segmentation reinforces the necessity for localized strategies that address distinct regulatory, cultural, and economic circumstances, thereby highlighting how regional factors shape the evolution of cardiac safety services globally.

Overall, these regional insights signal that market dynamics are influenced not only by technological and methodological advancements but also by inherent regional disparities. By understanding these differences, stakeholders can design targeted strategies that effectively navigate the concurrent challenges and opportunities present in each region.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New York, North Carolina, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Company Insights Unveiling Leaders in Cardiac Safety Services

An analysis of the key companies driving the cardiac safety services market uncovers a vibrant landscape marked by both longstanding institutions and innovative newcomers. Industry leaders include organizations such as ACM Global Laboratories and Advarra, Inc., alongside influential players like Banook Group, Biotrial, and Celerion. These companies have garnered industry recognition for their expertise in integrating advanced methodologies and comprehensive clinical trial assessments.

Moreover, the market is further defined by the contributions of entities like Certara, Inc. and Charles River Laboratories International, Inc. which have historically set high standards for safety and regulatory compliance. Other influential companies such as Circle Cardiovascular Imaging Inc. and Clario exemplify the integration of state-of-the-art imaging and monitoring technologies, while Clyde Biosciences Limited and Eurofins Scientific SE underscore the importance of a multi-faceted analytical approach.

Outstanding market players also include GE HealthCare Technologies Inc., ICON PLC, and IQVIA Holdings Inc., whose expansive operational expertise has significantly shaped industry standards. Additionally, global brands such as Koninklijke Philips N.V. and Laboratory Corporation of America Holdings are innovating in the realms of diagnostic imaging and patient monitoring systems, respectively. Among other notable contributors are Medpace, Inc., MERIT CRO, Inc., and Metrion Biosciences Limited, which have each demonstrated a commitment to scientific rigor and process optimization.

A closer look at companies such as Ncardia Services B.V., NEXEL Co., Ltd., Octagos Health, Inc., and Parexel International Corporation further reveals a drive for innovation that not only enhances clinical outcomes but also optimizes operational efficiencies. Other key contributors, including PhysioStim SAS, PPD, Inc. by Thermo Fisher Scientific Inc., Richmond Pharmacology Limited, Shanghai Medicilon Inc., and Worldwide Clinical Trials, collectively ensure that the market remains agile, responsive, and primed to meet evolving demands.

This diverse representation of top-tier organizations reflects a robust competitive landscape and indicates a strong trend towards the amalgamation of technology, research, and patient-centric care within the global cardiac safety services market.

The report delves into recent significant developments in the Cardiac Safety Services Market, highlighting leading vendors and their innovative profiles. These include ACM Global Laboratories, Advarra, Inc., Banook Group, Biotrial, Celerion, Certara, Inc., Charles River Laboratories International, Inc., Circle Cardiovascular Imaging Inc., Clario, Clyde Biosciences Limited, Eurofins Scientific SE, GE HealthCare Technologies Inc., ICON PLC, IQVIA Holdings Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Medpace, Inc., MERIT CRO, Inc., Metrion Biosciences Limited, Ncardia Services B.V., NEXEL Co., Ltd., Octagos Health, Inc., Parexel International Corporation, PhysioStim SAS, PPD, Inc. by Thermo Fisher Scientific Inc., Richmond Pharmacology Limited, Shanghai Medicilon Inc., and Worldwide Clinical Trials. Actionable Recommendations for Industry Leaders

To maintain competitive advantages and drive sustained market growth, industry leaders need to adopt proactive strategies that address both current challenges and future opportunities in the cardiac safety services sector. Emphasizing the integration of advanced diagnostic tools and digital solutions is paramount. Stakeholders are encouraged to invest in high-throughput imaging technologies, automated analytical tools, and cloud-based data management systems that can substantially enhance the efficiency and accuracy of cardiac assessments.

Strategic investments in innovation should be complemented by a commitment to continuous workforce training. This approach ensures that clinical teams are proficient in the latest protocols and technologies, thereby reducing error margins and accelerating the pace at which therapeutic candidates advance through clinical pipelines. Furthermore, forming collaborative partnerships across research institutions and technology firms can enrich the available pool of expertise, foster innovative synergies, and ultimately deliver high-quality outcomes in clinical safety evaluations.

It is essential for decision-makers to adopt a segmented approach to market engagement, tailoring solutions to meet the unique needs of service types, applications, and end-user groups. A deep understanding of regional disparities will also empower companies to design localized strategies that reflect the distinct regulatory, cultural, and economic landscapes inherent in different geographies.

In addition, organizations should actively monitor the competitive environment through the integration of real-time data analytics. This enables a responsive management strategy that can swiftly adjust to emerging trends or regulatory shifts, thereby enabling a more agile operational model. In doing so, industry leaders can not only streamline operations but also preemptively mitigate potential risks associated with market volatility.

Ultimately, the pathway to sustained success in cardiac safety services lies in blending technological innovation with a robust, segmented market strategy. Leaders who can navigate the intricate tapestry of clinical, technological, and regulatory elements will be best positioned to spearhead the next wave of industry evolution.

Conclusion: Reflecting on the Evolving Cardiac Safety Paradigm

In conclusion, the cardiac safety services domain is evolving at an unprecedented pace, driven by technological breakthroughs, strategic collaborations, and comprehensive segmentation strategies that cater to a multi-dimensional market environment. Throughout this report, we have examined the transformative shifts that are reshaping the clinical safety landscape and identified key market segmentation factors that inform not only the service delivery models but also the end-user strategies.

The growing emphasis on digital innovation and high-throughput data analysis has revolutionized traditional methodologies, enabling faster, more accurate assessments of cardiac safety. Simultaneously, an in-depth understanding of regional dynamics and a keen focus on top-tier industry players have illustrated the global interconnectedness of clinical safety research. These factors collectively underscore the necessity for a forward-thinking, nuanced approach to the challenges and opportunities embedded in the cardiac safety services market.

The insights presented herein affirm that the future of cardiac safety lies in the ability to integrate diverse data sources, technological innovations, and regional considerations into a cohesive strategy that drives patient outcomes while ensuring compliance with stringent regulatory standards. By synthesizing these disparate elements, stakeholders are equipped to navigate an increasingly complex market landscape with confidence and precision.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased incidence of heart-related ailments & rising need for novel drug development globally
      • 5.1.1.2. Rising CRO outsourcing services by pharmaceutical firms
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with integration of cardiac safety technologies with existing healthcare IT infrastructures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing integration of artificial intelligence and machine learning improving the accuracy of cardiac monitoring
      • 5.1.3.2. Increasing public- private investment in novel clinical research
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory compliance and incentives associated with cardiac safety services
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Service Type: Rising need of holter measurement services for monitoring the drug's effect on cardiac rhythm
    • 5.2.2. Type: Utilization of standalone services due to flexibility and precision in targeting precise cardiac parameters
    • 5.2.3. Application: Preference for drug & device development enhances the detection of cardiac side effects
    • 5.2.4. End User: Innovations in cardiac safety evolving role of contract research organizations in clinical trials
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Safety Services Market, by Service Type

  • 6.1. Introduction
  • 6.2. Blood Pressure Measurement Services
  • 6.3. Cardiovascular Imaging Services
  • 6.4. ECG or Holter Measurement Services
  • 6.5. Thorough QT Studies

7. Cardiac Safety Services Market, by Type

  • 7.1. Introduction
  • 7.2. Integrated Services
  • 7.3. Standalone Services

8. Cardiac Safety Services Market, by Application

  • 8.1. Introduction
  • 8.2. Drug & Device Development
  • 8.3. Regulatory Compliance Requirements

9. Cardiac Safety Services Market, by End User

  • 9.1. Introduction
  • 9.2. Contract Research Organizations
  • 9.3. Pharmaceutical & Biopharma
  • 9.4. Research Institutes

10. Americas Cardiac Safety Services Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cardiac Safety Services Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac Safety Services Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Medera's Novoheart and Curi Bio collaborate for advancements in cardiac drug screening
    • 13.3.2. Lindus Health launches All-in-One cardiovascular CRO for streamlined clinical trials
    • 13.3.3. Medicalgorithmics expands into clinical trials with AI-driven cardiac safety services
    • 13.3.4. CSRC think tank program advancing cardiac safety through remote monitoring and AI integration
    • 13.3.5. Clario and AliveCor partnered to enhance cardiac safety monitoring in decentralized clinical trials
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. Banook Group
    • 13.4.2. Clario
    • 13.4.3. ICON PLC
    • 13.4.4. IQVIA Holdings Inc.

Companies Mentioned

  • 1. ACM Global Laboratories
  • 2. Advarra, Inc.
  • 3. Banook Group
  • 4. Biotrial
  • 5. Celerion
  • 6. Certara, Inc.
  • 7. Charles River Laboratories International, Inc.
  • 8. Circle Cardiovascular Imaging Inc.
  • 9. Clario
  • 10. Clyde Biosciences Limited
  • 11. Eurofins Scientific SE
  • 12. GE HealthCare Technologies Inc.
  • 13. ICON PLC
  • 14. IQVIA Holdings Inc.
  • 15. Koninklijke Philips N.V.
  • 16. Laboratory Corporation of America Holdings
  • 17. Medpace, Inc.
  • 18. MERIT CRO, Inc.
  • 19. Metrion Biosciences Limited
  • 20. Ncardia Services B.V.
  • 21. NEXEL Co., Ltd.
  • 22. Octagos Health, Inc.
  • 23. Parexel International Corporation
  • 24. PhysioStim SAS
  • 25. PPD, Inc. by Thermo Fisher Scientific Inc.
  • 26. Richmond Pharmacology Limited
  • 27. Shanghai Medicilon Inc.
  • 28. Worldwide Clinical Trials

LIST OF FIGURES

  • FIGURE 1. CARDIAC SAFETY SERVICES MARKET MULTI-CURRENCY
  • FIGURE 2. CARDIAC SAFETY SERVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. CARDIAC SAFETY SERVICES MARKET RESEARCH PROCESS
  • FIGURE 4. CARDIAC SAFETY SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CARDIAC SAFETY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CARDIAC SAFETY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC SAFETY SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC SAFETY SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY BLOOD PRESSURE MEASUREMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY CARDIOVASCULAR IMAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY ECG OR HOLTER MEASUREMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY THOROUGH QT STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY INTEGRATED SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY STANDALONE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY DRUG & DEVICE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGULATORY COMPLIANCE REQUIREMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. CARDIAC SAFETY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. CARDIAC SAFETY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023